ON THIS PAGE: You will find information about the number of people who are diagnosed with testicular cancer each year. You will also read general information on surviving the disease. Remember, survival rates depend on several factors. Use the menu to see other pages.
This year, an estimated 9,910 people in the United States will be diagnosed with testicular cancer. About 1 out of every 250 men and boys will be diagnosed with the disease during their lifetime. Worldwide, an estimated 74,458 people were diagnosed with testicular cancer in 2020.
Testicular cancer is one of the most commonly diagnosed cancers in young adult men, particularly between ages 30 and 39. In 2020, there were an estimated 3,100 new cases of the disease in the United States among people aged 30 to 39 and 3,000 new cases in the United States among people aged 20 to 29.
The average age of diagnosis is 33. However, the disease can occur at any age. Approximately 6% of cases are diagnosed in children and teens. An estimated 8% of cases are diagnosed in men 56 or older.
For unknown reasons, the number of testicular cancer cases has increased for many decades. However, the rate of increase has slowed down recently.
It is estimated that 460 deaths from this disease will occur in the United States this year. These deaths are either from cancer that spread from the testicles to other parts of the body and could not be effectively treated with chemotherapy, radiation therapy, and/or surgery or from complications from treatment. In 2020, an estimated 9,334 people worldwide died from testicular cancer.
The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The general 5-year survival rate for people with testicular cancer in the United States is 95%. This means that 95 out of every 100 people diagnosed with testicular cancer will live at least 5 years after diagnosis.
The survival rate is higher for people diagnosed with early-stage cancer and lower for those with later-stage cancer. For testicular cancer that has not spread beyond the testicles (stage 1; see Stages), the survival rate is 99%. Approximately 68% of cases are diagnosed at this stage.
For testicular cancer that has spread to the lymph nodes in the back of the abdomen, called the retroperitoneal lymph nodes, the survival rate is 96%. But this depends on the size of the lymph nodes with cancer. About 18% of cases are diagnosed at this stage.
For testicular cancer that has spread outside the testicles to areas beyond the retroperitoneal lymph nodes, such as to the lungs or other organs, the survival rate is 73%. About 12% of testicular cancer is diagnosed at this stage.
It is important to remember that statistics on the survival rates for people with testicular cancer are an estimate. The estimate comes from annual data based on the number of people with this cancer in the United States. Also, 5-year survival estimates are based on information that is at least 5 years old. This means the estimate may not reflect the results of advancements in how testicular cancer is diagnosed or treated from the last 5 years. Talk with your doctor if you have any questions about this information. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society's (ACS) publications, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020, the ACS website, the International Agency for Research on Cancer website, and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. (All sources accessed January 2022.)
The next section in this guide is Medical Illustrations. It offers drawings of body parts often affected by testicular cancer. Use the menu to choose a different section to read in this guide.